Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: BIOMARKER STRATEGIES LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-16 to 2023-09-15
Current total value of award: $1498027
Description: SBIR TOPIC 354: A NOVEL PREDICTIVE TEST FOR RESPONSE TO COMBINATION IMMUNOTHERAPIES FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)